Cargando…

Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer

Toll-like receptor-9 (TLR9) is an intracellular DNA receptor that is widely expressed in breast and other cancers. We previously demonstrated that low tumor TLR9 expression upon diagnosis is associated with significantly shortened disease-specific survival times in patients with triple-negative brea...

Descripción completa

Detalles Bibliográficos
Autores principales:	TUOMELA, JOHANNA, SANDHOLM, JOUKO, KAUPPILA, JOONAS H., LEHENKARI, PETRI, HARRIS, KEVIN W., SELANDER, KATRI S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835157/ https://www.ncbi.nlm.nih.gov/pubmed/24273604 http://dx.doi.org/10.3892/ol.2013.1602

Ejemplares similares

Hypoxia regulates Toll-like receptor-9 expression and invasive function in human brain cancer cells in vitro
por: SANDHOLM, JOUKO, et al.
Publicado: (2014)

CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
por: Petruk, Nataliia, et al.
Publicado: (2021)

CD73 regulates zoledronate-induced lymphocyte infiltration in triple-negative breast cancer tumors and lung metastases
por: Petruk, Nataliia, et al.
Publicado: (2023)

Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo
por: Sandholm, Jouko, et al.
Publicado: (2016)

Toll-Like Receptor 9 in Breast Cancer
por: Sandholm, Jouko, et al.
Publicado: (2014)

Toll-Like Receptors in Esophageal Cancer
por: Kauppila, Joonas H., et al.
Publicado: (2014)

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2019)

Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans
por: Chandler, Madison R., et al.
Publicado: (2017)

Toll-like receptors 1, 2, 4 and 6 in esophageal epithelium, Barrett's esophagus, dysplasia and adenocarcinoma
por: Huhta, Heikki, et al.
Publicado: (2016)

Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma
por: Huhta, Heikki, et al.
Publicado: (2017)

Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells
por: Virtanen, Sanna S., et al.
Publicado: (2018)

Inhibition of c-Abl Kinase Activity Renders Cancer Cells Highly Sensitive to Mitoxantrone
por: Alpay, Kemal, et al.
Publicado: (2014)

The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer
por: Huhta, Heikki, et al.
Publicado: (2016)

Tenascin-C and fibronectin in normal esophageal mucosa, Barrett’s esophagus, dysplasia and adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2017)

Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers
por: Anselmino, L. E., et al.
Publicado: (2023)

Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
por: Caiazza, F, et al.
Publicado: (2015)

Molecular classification of triple-negative tumors
por: Prat, A, et al.
Publicado: (2011)

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
por: Ronkainen, Hanna, et al.
Publicado: (2011)

Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition
por: Siddiqui, Arafat, et al.
Publicado: (2021)

Evaluation of [(18)F]F-DPA as a target for TSPO in head and neck cancer under normal conditions and after radiotherapy
por: Tuominen, Sanni, et al.
Publicado: (2020)

Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
por: Leppänen, Joni, et al.
Publicado: (2018)

Humanin Promotes Tumor Progression in Experimental Triple Negative Breast Cancer
por: Moreno Ayala, Mariela A., et al.
Publicado: (2020)

Phenotypic characterization of circulating tumor cells in triple negative breast cancer patients
por: Agelaki, Sofia, et al.
Publicado: (2016)

Cathepsin K Is Present in Invasive Oral Tongue Squamous Cell Carcinoma In Vivo and In Vitro
por: Bitu, Carolina C., et al.
Publicado: (2013)

The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
por: Fan, Yiqi, et al.
Publicado: (2022)

Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts
por: Tuomela, Johanna, et al.
Publicado: (2010)

Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes
por: Kuroda, H., et al.
Publicado: (2021)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
por: Loizides, Sotiris, et al.
Publicado: (2023)

Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups
por: Sundquist, Elias, et al.
Publicado: (2017)

Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer
por: Papakonstantinou, Efthymia, et al.
Publicado: (2022)

Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2011)

Stimulation of triple negative breast cancer cell migration and metastases formation is prevented by chloroquine in a pre-irradiated mouse model
por: Bouchard, Gina, et al.
Publicado: (2016)

Chloroquine anticancer activity is mediated by autophagy-independent effects on the tumor vasculature
por: Maes, Hannelore, et al.
Publicado: (2015)

Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells
por: Valla, Sofía, et al.
Publicado: (2021)

Circulating tumor cells in non-metastatic triple-negative breast cancer
por: Karhade, Mandar, et al.
Publicado: (2014)

Integrative analysis of the inter-tumoral heterogeneity of triple-negative breast cancer
por: Chiu, Alec M., et al.
Publicado: (2018)

Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer
por: Zhang, Qian-Qian, et al.
Publicado: (2017)

Moderate Exercise Modulates Tumor Metabolism of Triple-Negative Breast Cancer
por: Vulczak, Anderson, et al.
Publicado: (2020)

Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer
por: Qiu, Xia, et al.
Publicado: (2022)

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
por: Zheng, Hongmei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hqv76jd1ge5pii2bvt8sku28b8